Chemical inhibition of TGS1 as therapeutic treatment for telomeropathies
Congenital dyskeratosisSinefunginTelomeresTelomeropathiesTGS1
Patent filed for less than 18 months, still in the period of secrecy
Register to get more information and contact the inventors.
REGISTRATION